<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bukhbinder AS</submitter><funding>NCATS NIH HHS</funding><pagination>1323-1339</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10200241</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>92(4)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Accurately identifying cognitive changes in Mexican American (MA) adults using the Mini-Mental State Examination (MMSE) requires knowledge of population-based norms for the MMSE, a scale which has widespread use in research settings.&lt;h4>Objective&lt;/h4>To describe the distribution of MMSE scores in a large cohort of MA adults, assess the impact of MMSE requirements on their clinical trial eligibility, and explore which factors are most strongly associated with their MMSE scores.&lt;h4>Methods&lt;/h4>Visits between 2004-2021 in the Cameron County Hispanic Cohort were analyzed. Eligible participants were ≥18 years old and of Mexican descent. MMSE distributions before and after stratification by age and years of education (YOE) were assessed, as was the proportion of trial-aged (50-85- year-old) participants with MMSE &lt;24, a minimum MMSE cutoff most frequently used in Alzheimer's disease (AD) clinical trials. As a secondary analysis, random forest models were constructed to estimate the relative association of the MMSE with potentially relevant variables.&lt;h4>Results&lt;/h4>The mean age of the sample set (n = 3,404) was 44.4 (SD, 16.0) years old and 64.5% female. Median MMSE was 28 (IQR, 28-29). The percentage of trial-aged participants (n = 1,267) with MMSE &lt;24 was 18.6% overall and 54.3% among the subset with 0-4 YOE (n = 230). The five variables most associated with the MMSE in the study sample were education, age, exercise, C-reactive protein, and anxiety.&lt;h4>Conclusion&lt;/h4>The minimum MMSE cutoffs in most phase III prodromal-to-mild AD trials would exclude a significant proportion of trial-aged participants in this MA cohort, including over half of those with 0-4 YOE.</pubmed_abstract><journal>Journal of Alzheimer's disease : JAD</journal><pubmed_title>Population-Based Mini-Mental State Examination Norms in Adults of Mexican Heritage in the Cameron County Hispanic Cohort.</pubmed_title><pmcid>PMC10200241</pmcid><funding_grant_id>UL1 TR000371</funding_grant_id><pubmed_authors>Hinojosa M</pubmed_authors><pubmed_authors>Cui L</pubmed_authors><pubmed_authors>McCormick JB</pubmed_authors><pubmed_authors>Fisher-Hoch SP</pubmed_authors><pubmed_authors>Chung K</pubmed_authors><pubmed_authors>Shyer M</pubmed_authors><pubmed_authors>Cooper S</pubmed_authors><pubmed_authors>Zhang GQ</pubmed_authors><pubmed_authors>Farrell CM</pubmed_authors><pubmed_authors>Sciba L</pubmed_authors><pubmed_authors>Hunter DH</pubmed_authors><pubmed_authors>Bukhbinder AS</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Ortiz GJ</pubmed_authors><pubmed_authors>Vargas AF</pubmed_authors><pubmed_authors>Schulz PE</pubmed_authors><pubmed_authors>Goodwin N</pubmed_authors><pubmed_authors>Anjum S</pubmed_authors><pubmed_authors>Harris K</pubmed_authors><pubmed_authors>Hasan O</pubmed_authors></additional><is_claimable>false</is_claimable><name>Population-Based Mini-Mental State Examination Norms in Adults of Mexican Heritage in the Cameron County Hispanic Cohort.</name><description>&lt;h4>Background&lt;/h4>Accurately identifying cognitive changes in Mexican American (MA) adults using the Mini-Mental State Examination (MMSE) requires knowledge of population-based norms for the MMSE, a scale which has widespread use in research settings.&lt;h4>Objective&lt;/h4>To describe the distribution of MMSE scores in a large cohort of MA adults, assess the impact of MMSE requirements on their clinical trial eligibility, and explore which factors are most strongly associated with their MMSE scores.&lt;h4>Methods&lt;/h4>Visits between 2004-2021 in the Cameron County Hispanic Cohort were analyzed. Eligible participants were ≥18 years old and of Mexican descent. MMSE distributions before and after stratification by age and years of education (YOE) were assessed, as was the proportion of trial-aged (50-85- year-old) participants with MMSE &lt;24, a minimum MMSE cutoff most frequently used in Alzheimer's disease (AD) clinical trials. As a secondary analysis, random forest models were constructed to estimate the relative association of the MMSE with potentially relevant variables.&lt;h4>Results&lt;/h4>The mean age of the sample set (n = 3,404) was 44.4 (SD, 16.0) years old and 64.5% female. Median MMSE was 28 (IQR, 28-29). The percentage of trial-aged participants (n = 1,267) with MMSE &lt;24 was 18.6% overall and 54.3% among the subset with 0-4 YOE (n = 230). The five variables most associated with the MMSE in the study sample were education, age, exercise, C-reactive protein, and anxiety.&lt;h4>Conclusion&lt;/h4>The minimum MMSE cutoffs in most phase III prodromal-to-mild AD trials would exclude a significant proportion of trial-aged participants in this MA cohort, including over half of those with 0-4 YOE.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023</publication><modification>2024-11-10T04:11:01.457Z</modification><creation>2024-11-10T04:11:01.457Z</creation></dates><accession>S-EPMC10200241</accession><cross_references><pubmed>36872776</pubmed><doi>10.3233/JAD-220934</doi></cross_references></HashMap>